CD8A and neoplasm: Specifically, this axis suppresses type I interferon signaling and abundance of antigen-experienced CD4+ and CD8+ T cells in the context of ovarian cancer14 and suppresses infiltration of CD8+ T cells in melanoma18, with potential impacts on immune contexture of other tumor types yet to be explored.